Specifically, improved treatment requires research scientists, clinicians and biomedical engineers to (i) Determine the quantitative relationships between risk factors, genetic susceptibility and molecular mechanisms that underlie cellular interactions in the front and the back of the eye, (ii) Develop standardized tests to define where the optic neuropathy in a particular patient falls in the spectrum between normal aging and glaucoma, (iii) Develop novel technologies (such as optical coherence tomography) for early diagnosis (iv) Improve the efficacy of pharmacological agents that target TM while eliminating side effects and (v) Protect the pressure sensitive targets within the trabecular meshwork, retinal ganglion cells and glia
Strong cytoprotective and antioxidative properties of quercetin help in inhibiting endothelial cell apoptosis induced by oxidants (Choi et al
This increases the likelihood of the addiction aspect
Its about understanding biology better so we can protect future children, and more importantly, so we can develop treatments that actually help the children and families we care for today
10.1093/jnci/91.3.252 59 HongS.TianH.LuY.LabordeJ
From mechanism to phenotype: What fits in a basket trial
